NAVLE Gastrointestinal and Digestive

Canine Hemorrhagic Gastroenteritis Study Guide

Acute Hemorrhagic Diarrhea Syndrome (AHDS), formerly known as hemorrhagic gastroenteritis (HGE), is a common and potentially life-threatening gastrointestinal emergency in dogs characterized by the acute onset of profuse, bloody diarrhea with severe...

Overview and Clinical Importance

Acute Hemorrhagic Diarrhea Syndrome (AHDS), formerly known as hemorrhagic gastroenteritis (HGE), is a common and potentially life-threatening gastrointestinal emergency in dogs characterized by the acute onset of profuse, bloody diarrhea with severe hemoconcentration. This syndrome represents one of the most important causes of acute hemorrhagic diarrhea in canine patients and is frequently tested on the NAVLE.

The condition predominantly affects young to middle-aged small and toy breed dogs. Understanding the pathophysiology, clinical presentation, diagnostic approach, and treatment protocols is essential for veterinary practitioners, as prompt recognition and aggressive supportive care are critical for successful outcomes.

Factor Description
Age Young to middle-aged (median age: 5 years)
Breed Small and toy breeds highly overrepresented
Sex No sex predilection documented
Body Condition Often previously healthy dogs

Etiology and Pathophysiology

Suspected Cause

The precise etiology of AHDS remains incompletely understood, but current evidence strongly implicates Clostridium perfringens type A and its associated pore-forming toxins, particularly NetF (necrotic enteritis toxin F). C. perfringens is a Gram-positive, anaerobic, spore-forming bacillus that is part of the normal intestinal flora in dogs. However, certain toxigenic strains carrying the netF gene appear to be responsible for the severe intestinal damage seen in AHDS.

Key Toxins Involved

  • NetF toxin: A beta-pore-forming toxin belonging to the leucocidin/hemolysin superfamily that causes plasma membrane destruction and osmotic cell lysis
  • NetE toxin: Often co-expressed with NetF; exact role still being investigated
  • CPE (enterotoxin): May contribute to intestinal damage in some cases
High-YieldResearch shows that netF-positive C. perfringens is found in approximately 48% of dogs with AHDS compared to only 12% of healthy dogs. The prevalence is 0% in dogs with canine parvovirus infection, helping to distinguish these two conditions.

Pathophysiology

The pathophysiological mechanism involves clostridial overgrowth in the intestinal tract, likely triggered by dietary factors, stress, or immune dysregulation. The NetF toxin forms pores in the plasma membrane of intestinal epithelial cells, leading to:

  • Acute necrotizing enterocolitis: Mucosal necrosis primarily affecting the small and large intestine
  • Increased intestinal permeability: Leakage of fluid, plasma proteins, and red blood cells into the intestinal lumen
  • Massive fluid loss: Rapid dehydration and hemoconcentration
  • Protein loss: Hypoalbuminemia due to protein-losing enteropathy
NAVLE TipThe predisposition of small breed dogs to AHDS may be explained by their increased incidence of pancreatitis. Pancreatitis disrupts pancreatic trypsin production, and NetF toxin is normally susceptible to trypsin degradation. Reduced trypsin allows the toxin to persist and cause more severe intestinal damage.

Important Terminology Update

The term "hemorrhagic gastroenteritis" (HGE) has been replaced by "acute hemorrhagic diarrhea syndrome" (AHDS) because histological studies have shown that the stomach is typically NOT affected. Lesions are primarily found in the small and large intestine, with the most severe damage occurring in the colon.

Finding Clinical Significance
Severe dehydration Often 8-12% dehydrated; may have dry, tacky mucous membranes, prolonged skin turgor, sunken eyes
Signs of hypovolemic shock Tachycardia, weak pulses, prolonged CRT (greater than 2 seconds), pale mucous membranes, hypotension
Abdominal palpation May reveal pain, fluid-filled intestinal loops, or be unremarkable
Temperature Usually NORMAL or hypothermic; fever is UNCOMMON (helps differentiate from infectious causes)
Depression Mental dullness secondary to hypovolemia and poor perfusion

Signalment and Risk Factors

Classic Signalment

Predisposed Breeds

  • Yorkshire Terrier
  • Miniature Schnauzer
  • Miniature Poodle
  • Miniature Pinscher
  • Maltese
  • Cavalier King Charles Spaniel
  • Dachshund
  • Chihuahua
  • Bichon Frise
  • Shetland Sheepdog
Test Expected Finding Clinical Significance
PCV/HCT Greater than 57-60% (normal: 37-55%) Severe hemoconcentration from massive fluid loss into GI tract
Total Protein Normal to LOW KEY finding: protein is lost into the intestinal lumen; in simple dehydration, TP would be elevated
WBC Variable: normal, leukocytosis, or leukopenia Leukopenia may indicate severe disease or sepsis; monitor closely
BUN/Creatinine Elevated (prerenal azotemia) Secondary to severe dehydration and decreased renal perfusion
Electrolytes May show hypokalemia, metabolic acidosis GI losses lead to electrolyte derangements; monitor and supplement K+
Glucose May be low in small breeds Hypoglycemia more common in toy breeds; supplement dextrose if needed

Clinical Presentation

History

Dogs with AHDS typically present with a peracute onset of clinical signs. The owner often reports that the dog was completely healthy just 12-24 hours prior to presentation. Key historical findings include:

  • Vomiting: Often precedes diarrhea by 10-12 hours; present in approximately 80% of cases
  • Acute hemorrhagic diarrhea: Profuse, watery, bloody; classically described as having a "raspberry jam" appearance
  • Anorexia and lethargy: Rapid onset of depression and decreased appetite
  • No significant prior history: Vaccination status is typically unremarkable; no known dietary indiscretion in most cases

Physical Examination Findings

High-YieldA key distinguishing feature of AHDS is that fever is typically ABSENT. If a dog with hemorrhagic diarrhea presents with fever, consider other differentials such as parvovirus, salmonellosis, or sepsis more strongly.
Condition Key Distinguishing Features Diagnostic Test
Canine Parvovirus Young, unvaccinated dogs; LEUKOPENIA; LOW PCV (anemia from blood loss); fever common Fecal parvovirus ELISA or PCR
Acute Pancreatitis Cranial abdominal pain, vomiting predominant, history of dietary indiscretion or fatty meal cPL (SNAP or Spec cPL), abdominal ultrasound
Foreign Body/Obstruction Progressive vomiting, palpable mass or dilated loops, history of ingesting objects Abdominal radiographs, ultrasound
Hypoadrenocorticism Waxing/waning history, classic electrolyte changes (hyperkalemia, hyponatremia), bradycardia Baseline cortisol (less than 2 μg/dL requires ACTH stim)
Intussusception Palpable tubular mass, progressive worsening despite fluids Abdominal ultrasound ("target sign")
Coagulopathy Rodenticide exposure history, petechiae/ecchymoses, bleeding from multiple sites PT/PTT, platelet count
Intestinal Parasites Especially in young dogs; hookworms and whipworms can cause hemorrhagic diarrhea Fecal flotation, antigen testing

Diagnosis

AHDS is a diagnosis of exclusion. There is no single confirmatory test. Diagnosis is based on the combination of signalment, acute clinical presentation, and characteristic laboratory findings after ruling out other causes of acute hemorrhagic diarrhea.

Diagnostic Criteria

The following criteria support a clinical diagnosis of AHDS:

  • Sudden onset of watery, bloody diarrhea (often resembles raspberry jam or straight blood)
  • Vomiting (at least one episode, typically within 10-12 hours before diarrhea onset)
  • Elevated PCV: Greater than 57-60% (often greater than 60% in 30% of cases)
  • Normal to LOW total protein: This is the KEY finding that distinguishes AHDS from simple dehydration
  • Small or toy breed dog, young to middle-aged

Laboratory Findings

NAVLE TipThe hallmark laboratory finding for AHDS on the NAVLE is ELEVATED PCV with NORMAL or LOW total protein. In simple dehydration, both PCV and total protein would be elevated proportionally. The discrepancy occurs because protein is being lost into the intestinal lumen while red blood cells are retained.

Differential Diagnosis

The following conditions must be ruled out before diagnosing AHDS:

Phase Protocol Details
1. Resuscitation Goal: Restore intravascular volume and perfusion Fluid type: Balanced isotonic crystalloid (LRS or Plasmalyte preferred) Rate: Initial bolus 20-40 mL/kg IV over 15-30 minutes Reassess: Heart rate, pulse quality, CRT, blood pressure after each bolus
2. Replacement Goal: Replace fluid deficit over 6-24 hours Calculation: % dehydration x body weight (kg) x 10 = mL deficit Plus: Add maintenance (40-60 mL/kg/day) + ongoing losses
3. Maintenance Continue: IV fluids until eating and drinking, PCV normalizing Monitor: Body weight every 8-12 hours, PCV/TP every 12-24 hours Supplement: Potassium chloride 20-40 mEq/L as needed
4. Colloid Support Indication: Severe hypoproteinemia (TP less than 4.0 g/dL) or refractory hypotension Options: Fresh frozen plasma, synthetic colloids (if available)

Treatment

The mainstay of treatment for AHDS is aggressive intravenous fluid therapy to restore circulating volume, correct dehydration, and maintain tissue perfusion. Most dogs respond dramatically within 24-48 hours with appropriate supportive care.

Fluid Therapy Protocol

High-YieldSUBCUTANEOUS fluids are NOT adequate for AHDS patients. These patients require aggressive IV fluid therapy to maintain intravascular volume. The GI tract is the "shock organ" in dogs, and poor perfusion will perpetuate intestinal damage.

Supportive Care and Medications

Antibiotic Therapy

Important Update: Routine antibiotic use in AHDS is NOT recommended in uncomplicated cases. A prospective study demonstrated that dogs with AHDS and no signs of sepsis showed no difference in outcome when treated with amoxicillin-clavulanic acid compared to no antibiotics.

Indications for Antibiotics

  • Signs of sepsis (fever, hypotension despite fluids, altered mentation)
  • Severe neutropenia (less than 1,500/μL) or neutrophilia with degenerative left shift
  • Immunocompromised patient
  • Failure to improve with appropriate fluid therapy

Antibiotic Choices (When Indicated)

  • Ampicillin: 20-40 mg/kg IV every 6-8 hours
  • Metronidazole: 10-15 mg/kg IV every 12 hours (covers anaerobes)
  • If sepsis suspected: Add gram-negative coverage (enrofloxacin 5-20 mg/kg IV q24h in dogs)
NAVLE TipOn the NAVLE, remember that antibiotics are NOT first-line treatment for uncomplicated AHDS. The primary treatment is aggressive IV fluid therapy. Antibiotics may do more harm than good by disrupting the intestinal microbiome. Reserve antibiotics for patients with signs of sepsis or severe neutropenia.

Nutritional Management

  • Early enteral nutrition: Once vomiting is controlled, introduce small amounts of highly digestible food
  • Diet selection: Low-fat, highly digestible GI diet (commercial GI therapeutic diet or boiled chicken/white rice)
  • Feeding schedule: Small, frequent meals (3-6 times daily initially)
  • Enteral tube feeding: Consider NG or NE tube if prolonged anorexia or severe hypoproteinemia
Medication Class Drug/Dose Notes
Antiemetics Maropitant (Cerenia): 1 mg/kg IV/SC q24h Ondansetron: 0.1-0.2 mg/kg IV q8-12h Essential for controlling nausea and vomiting; maropitant also has visceral analgesic properties
Gastroprotectants Famotidine: 0.5-1 mg/kg IV/PO q12-24h Sucralfate: 0.5-1 g PO q8-12h May help protect damaged mucosa; use if hematemesis present
Prokinetics Metoclopramide: 0.2-0.5 mg/kg CRI or 0.2 mg/kg SC q8h May help with gastric motility and reduce ileus from hypoperfusion
Dextrose 2.5-5% dextrose in IV fluids Supplement if hypoglycemic; especially important in toy breeds
Probiotics Veterinary formulations as directed May help restore microbiome; continue for 2-4 weeks after recovery

Prognosis and Complications

Prognosis

The prognosis for AHDS is EXCELLENT with prompt, aggressive treatment. Most dogs show dramatic improvement within 24-48 hours and are discharged within 2-4 days. Key prognostic points:

  • Mortality rate: Less than 10% in hospitalized dogs with appropriate care
  • Recovery time: Full stool normalization typically occurs within 7-10 days
  • Without treatment: Can be rapidly fatal due to hypovolemic shock
  • Recurrence: Some dogs may be prone to repeated episodes

Potential Complications

  • Hypovolemic shock: Most common cause of death if untreated
  • Severe hypoproteinemia: May lead to peripheral edema, ascites
  • DIC (Disseminated Intravascular Coagulation): Rare but serious complication
  • Sepsis: Secondary to bacterial translocation across damaged intestinal mucosa
  • Chronic GI disease: Up to 30% of dogs may develop chronic GI disorders following AHDS
  • Aspiration pneumonia: Possible complication in severe vomiting

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →